QTTB Valuation

Q32 Bio Inc

Add to Watchlist

Advanced Chart

2.320

-0.07(-2.929%)1D

QTTB Relative Valuation

QTTB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, QTTB is overvalued; if below, it's undervalued.

Historical Valuation

Q32 Bio Inc (QTTB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.29. The fair price of Q32 Bio Inc (QTTB) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.35

Fair

-0.51

Trailing

Forward

0.00

EV/EBITDA

Q32 Bio Inc. (QTTB) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.33

EV/EBIT

Q32 Bio Inc. (QTTB) has a current EV/EBIT of 0.33. The 5-year average EV/EBIT is -2.56. The thresholds are as follows: Strongly Undervalued below -8.23, Undervalued between -8.23 and -5.40, Fairly Valued between 0.27 and -5.40, Overvalued between 0.27 and 3.10, and Strongly Overvalued above 3.10. The current Forward EV/EBIT of 0.33 falls within the Overvalued range.

0.00

Q32 Bio Inc. (QTTB) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

-0.51

P/OCF

Q32 Bio Inc. (QTTB) has a current P/OCF of -0.51. The 5-year average P/OCF is -3.39. The thresholds are as follows: Strongly Undervalued below -8.86, Undervalued between -8.86 and -6.13, Fairly Valued between -0.66 and -6.13, Overvalued between -0.66 and 2.08, and Strongly Overvalued above 2.08. The current Forward P/OCF of -0.51 falls within the Overvalued range.

0.00

P/FCF

Q32 Bio Inc. (QTTB) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.57. The thresholds are as follows: Strongly Undervalued below -11.17, Undervalued between -11.17 and -7.37, Fairly Valued between 0.23 and -7.37, Overvalued between 0.23 and 4.03, and Strongly Overvalued above 4.03. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Q32 Bio Inc (QTTB) has a current Price-to-Book (P/B) ratio of -5.53. Compared to its 3-year average P/B ratio of 7.64 , the current P/B ratio is approximately -172.40% higher. Relative to its 5-year average P/B ratio of 7.64, the current P/B ratio is about -172.40% higher. Q32 Bio Inc (QTTB) has a Forward Free Cash Flow (FCF) yield of approximately -283.58%. Compared to its 3-year average FCF yield of -105.75%, the current FCF yield is approximately 168.16% lower. Relative to its 5-year average FCF yield of -105.75% , the current FCF yield is about 168.16% lower.

-5.53

P/B

Median3y

7.64

Median5y

7.64

-283.58

FCF Yield

Median3y

-105.75

Median5y

-105.75

Competitors Valuation Multiple

The average P/S ratio for QTTB's competitors is 1.29, providing a benchmark for relative valuation. Q32 Bio Inc Corp (QTTB) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Apimeds Pharmaceuticals US Inc

Incannex Healthcare Inc

Enlivex Therapeutics Ltd

1.00

24.29M

Performance Decomposition

Market capitalization of QTTB increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of QTTB in the past 1 year is driven by Unknown.